Entering text into the input field will update the search result below

Novus Therapeutics -7.8% on stockholder offer of 7.07M shares

Jun. 07, 2019 6:12 PM ETEledon Pharmaceuticals, Inc. (ELDN) StockELDNBy: Jason Aycock, SA News Editor
  • Novus Therapeutics (NASDAQ:NVUS) has slipped 7.8% in Friday postmarket action after a shareholder filing to offer just over 7.07M shares.
  • The company won't receive any proceeds from any sale of shares.
  • The company has just 12.9M shares outstanding. Along with several individuals, selling stockholders in the filing include entities affiliated with OrbiMed Israel Partners (holders of a 31.37% stake); BVF Partners (a 9.16% stake); Armistice Capital Master Fund (a 4.99% stake); and Lincoln Park Capital Fund (also a 4.99% stake).

Recommended For You

More Trending News

About ELDN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ELDN--
Eledon Pharmaceuticals, Inc.